These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22469521)

  • 81. Multiple Myeloma in Patients over 80: A Real World Retrospective Study of First Line Conservative Approach with Bortezomib Dexamethasone Doublet Therapy and Mini-Review of Literature.
    Huynh L; Birsen R; Mora L; Couderc AL; Mitha N; Farcet A; Chebib A; Chaibi P
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230662
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect
    Lee HC; Ailawadhi S; Gasparetto CJ; Jagannath S; Rifkin RM; Durie BGM; Narang M; Terebelo HR; Toomey K; Hardin JW; Wagner L; Omel JL; Dhalla M; Liu L; Joshi P; Abonour R;
    Blood Cancer J; 2021 Jul; 11(7):134. PubMed ID: 34301916
    [No Abstract]   [Full Text] [Related]  

  • 83. Diagnostic and Therapeutic Challenges in the Management of Intermediate and Frail Elderly Multiple Myeloma Patients.
    Bonello F; Boccadoro M; Larocca A
    Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33114320
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis.
    Schjesvold FH; Richardson PG; Facon T; Alegre A; Spencer A; Jurczyszyn A; Sunami K; Frenzel L; Min CK; Guillonneau S; Lin PL; Le-Guennec S; Campana F; van de Velde H; Bensfia S; Bringhen S
    Haematologica; 2021 Apr; 106(4):1182-1187. PubMed ID: 32586908
    [No Abstract]   [Full Text] [Related]  

  • 85. The characteristics, treatment patterns, and outcomes of older adults aged 80 and over with multiple myeloma.
    Fiala MA; Foley NC; Zweegman S; Vij R; Wildes TM
    J Geriatr Oncol; 2020 Nov; 11(8):1274-1278. PubMed ID: 32169544
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clinical features and treatment outcome of elderly multiple myeloma patients with impaired renal function.
    Chen J; Liu H; Li L; Liu Z; Song J; Wang G; Wang H; Ruan E; Ding K; Shao Z; Fu R
    J Clin Lab Anal; 2019 Jun; 33(5):e22888. PubMed ID: 31004381
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Challenges and Strategies in the Management of Multiple Myeloma in the Elderly Population.
    Zanwar S; Abeykoon JP; Kapoor P
    Curr Hematol Malig Rep; 2019 Apr; 14(2):70-82. PubMed ID: 30820879
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A phase I/II dose-escalation study investigating all-oral ixazomib-melphalan-prednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagnosed multiple myeloma.
    San-Miguel JF; Echeveste Gutierrez MA; Špicka I; Mateos MV; Song K; Craig MD; Bladé J; Hájek R; Chen C; Di Bacco A; Estevam J; Gupta N; Byrne C; Lu V; van de Velde H; Lonial S
    Haematologica; 2018 Sep; 103(9):1518-1526. PubMed ID: 29954932
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Early mortality in elderly patients undergoing treatment for multiple myeloma in real-world practice.
    Xia J; Wang L; Zhou X; Wang J; Wang H; Guo H
    J Int Med Res; 2018 Jun; 46(6):2230-2237. PubMed ID: 29584537
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Treat or palliate: outcomes of very elderly myeloma patients.
    Panitsas F; Kothari J; Vallance G; Djebbari F; Ferguson L; Sultanova M; Ramasamy K
    Haematologica; 2018 Jan; 103(1):e32-e34. PubMed ID: 29025911
    [No Abstract]   [Full Text] [Related]  

  • 91. Risk Stratification in Multiple Myeloma.
    Ooi MG; de Mel S; Chng WJ
    Curr Hematol Malig Rep; 2016 Apr; 11(2):137-47. PubMed ID: 26883334
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The outcomes of newly diagnosed elderly multiple myeloma patients treated at a single U.S. institution.
    Bonomo L; Lue J; Jagannath S; Chari A
    Cancer Med; 2016 Mar; 5(3):500-5. PubMed ID: 26799254
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The Applicability of the International Staging System in Chinese Patients with Multiple Myeloma Receiving Bortezomib or Thalidomide-Based Regimens as Induction Therapy: A Multicenter Analysis.
    Lu J; Lu J; Liu A; Fu W; Du J; Huang X; Chen W; Hou J
    Biomed Res Int; 2015; 2015():856704. PubMed ID: 26640799
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Management of Elderly Patients with Plasma Cell Myeloma.
    Campagnaro EL; Goebel TE; Lazarus HM
    Drugs Aging; 2015 Jun; 32(6):427-42. PubMed ID: 26025116
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Multiple myeloma in octogenarians: clinical features and outcome in the novel agent era.
    Dimopoulos MA; Kastritis E; Delimpasi S; Katodritou E; Hatzimichael E; Kyrtsonis MC; Repousis P; Tsirogianni M; Kartasis Z; Parcharidou A; Michael M; Michalis E; Tsatalas C; Stefanoudaki E; Hatjiharissi E; Gika D; Symeonidis A; Terpos E; Zervas K;
    Eur J Haematol; 2012 Jul; 89(1):10-5. PubMed ID: 22469521
    [TBL] [Abstract][Full Text] [Related]  

  • 96. High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agents.
    Terpos E; Katodritou E; Roussou M; Pouli A; Michalis E; Delimpasi S; Parcharidou A; Kartasis Z; Zomas A; Symeonidis A; Viniou NA; Anagnostopoulos N; Economopoulos T; Zervas K; Dimopoulos MA;
    Eur J Haematol; 2010 Aug; 85(2):114-9. PubMed ID: 20477863
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG).
    Kastritis E; Zervas K; Symeonidis A; Terpos E; Delimbassi S; Anagnostopoulos N; Michali E; Zomas A; Katodritou E; Gika D; Pouli A; Christoulas D; Roussou M; Kartasis Z; Economopoulos T; Dimopoulos MA
    Leukemia; 2009 Jun; 23(6):1152-7. PubMed ID: 19225533
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial.
    Dingli D; Rajkumar SV; Nowakowski GS; Gertz MA; Dispenzieri A; Lacy MQ; Hayman S; Fonseca R; Lust JA; Kyle RA; Greipp PR; Witzig TE
    Haematologica; 2005 Dec; 90(12):1650-4. PubMed ID: 16330438
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Shifts in the therapeutic paradigm for patients newly diagnosed with multiple myeloma: maintenance therapy and overall survival.
    Palumbo A; Attal M; Roussel M
    Clin Cancer Res; 2011 Mar; 17(6):1253-63. PubMed ID: 21411441
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?
    Klepin HD; Hurd DD
    Bone Marrow Transplant; 2006 Nov; 38(9):585-92. PubMed ID: 16953209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.